There was a plan. For the Washington Commanders, that wasn’t half the battle, it was all of it. They won four games last ...

The company reported revenue of $22.5 billion and adjusted earnings of $2.04 per share, compared to the consensus estimates ...

President Donald Trump during his latest campaign called tariff the “most beautiful word in the dictionary” and pledged to ...

While overdose death rates in the U.S. for white people have fallen dramatically, the rates for Black people lag behind.

Leerink Partners analyst Marc Goodman maintained a Buy rating on Johnson & Johnson (JNJ – Research Report) yesterday and set a price target ...

We look at the betting odds, picks and predictions for the PFL Champions Series: Road to Dubai fight card which has a main ...

President Donald Trump is poised to sign the first bill of his new administration. It's named after a slain Georgia nursing ...

How is one of the world’s largest pharmaceutical companies promoting sustainability and regulatory compliance throughout its ...

Michigan is in need of additional help in the secondary heading into the 2025 season. Will Johnson and Aamir Hall are both ...

Analysts discuss Johnson & Johnson's outlook, highlighting MedTech challenges, litigation risks, pipeline opportunities, and mixed performance across segments.

The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult ...

Analyst Tim Anderson of Bank of America Securities reiterated a Hold rating on Johnson & Johnson (JNJ – Research Report), reducing the ...